Captrust Financial Advisors bought a new stake in Healthequity Inc (NASDAQ:HQY) during the 4th quarter, HoldingsChannel.com reports. The fund bought 7,666 shares of the company’s stock, valued at approximately $457,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BlackRock Inc. increased its position in Healthequity by 1.6% in the 4th quarter. BlackRock Inc. now owns 6,764,271 shares of the company’s stock valued at $403,489,000 after acquiring an additional 109,127 shares during the period. Morgan Stanley increased its position in Healthequity by 15.5% in the 3rd quarter. Morgan Stanley now owns 4,001,425 shares of the company’s stock valued at $377,775,000 after acquiring an additional 536,366 shares during the period. FMR LLC increased its position in Healthequity by 2.3% in the 3rd quarter. FMR LLC now owns 3,488,107 shares of the company’s stock valued at $329,312,000 after acquiring an additional 77,565 shares during the period. Bank of New York Mellon Corp increased its position in Healthequity by 13.5% in the 4th quarter. Bank of New York Mellon Corp now owns 990,402 shares of the company’s stock valued at $59,076,000 after acquiring an additional 118,080 shares during the period. Finally, Credit Suisse AG increased its position in Healthequity by 14.3% in the 3rd quarter. Credit Suisse AG now owns 540,785 shares of the company’s stock valued at $51,057,000 after acquiring an additional 67,768 shares during the period. Hedge funds and other institutional investors own 95.46% of the company’s stock.

Shares of HQY stock opened at $81.70 on Friday. Healthequity Inc has a 1 year low of $50.29 and a 1 year high of $101.58. The firm has a market cap of $5.05 billion, a PE ratio of 151.30, a PEG ratio of 2.68 and a beta of 1.72.

HQY has been the topic of several analyst reports. Zacks Investment Research cut Healthequity from a “buy” rating to a “hold” rating in a research report on Tuesday, December 18th. Cantor Fitzgerald raised their target price on Healthequity from $80.00 to $82.00 and gave the company a “neutral” rating in a research report on Thursday, December 6th. ValuEngine cut Healthequity from a “buy” rating to a “hold” rating in a research report on Saturday, December 15th. Chardan Capital reiterated a “buy” rating and set a $78.00 price target (down from $82.00) on shares of Healthequity in a research report on Thursday, February 7th. Finally, SunTrust Banks upgraded Healthequity from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research report on Thursday, February 7th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and twelve have issued a buy rating to the stock. Healthequity has an average rating of “Buy” and an average target price of $87.85.

In related news, EVP Delano Ladd sold 6,875 shares of Healthequity stock in a transaction on Wednesday, February 20th. The stock was sold at an average price of $78.00, for a total value of $536,250.00. Following the transaction, the executive vice president now directly owns 14,340 shares in the company, valued at approximately $1,118,520. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction on Thursday, December 20th. The stock was sold at an average price of $60.28, for a total value of $241,120.00. Following the completion of the transaction, the vice president now owns 82,000 shares in the company, valued at $4,942,960. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 18,875 shares of company stock worth $1,332,090. 4.00% of the stock is owned by insiders.

WARNING: This piece was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://theolympiareport.com/2019/03/15/7666-shares-in-healthequity-inc-hqy-acquired-by-captrust-financial-advisors.html.

Healthequity Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: Benefits of owning preferred stock

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.